Skip to main content
. 2022 Feb 8;107(6):1727–1738. doi: 10.1210/clinem/dgac070

Table 2.

Overview copeptin cut-offs

Test/Indication Time point measurement Copeptin cut-off Test performance Reference
Random copeptin measurement Any time >21.4 pmol/L = nephrogenic diabetes insipidus Diagnostic accuracy 100% Timper K, et al. J Clin Endocrinol Metab 2015 (41)
Hypertonic saline infusion test Once plasma sodium ≥147 mmol/L ≤4.9 pmol/L = central diabetes insipidus Diagnostic accuracy 97% Fenske W, et al. N Engl J Med 2018 (43)
>4.9 pmol/L = primary polydipsia Timper K, et al. J Clin Endocrinol Metab 2015 (41)
Arginine infusion test 60 minutes after start of arginine infusion ≤3.8 pmol/L = central diabetes insipidus Diagnostic accuracy 93% Winzeler B, et al. Lancet 2019 (44)
>3.8 pmol/L = primary polydipsia
Pituitary surgery stimulated copeptin 1st postoperative day <2.5 pmol/L = central diabetes insipidus Positive predictive value 81%, specificity 97% Winzeler B, et al. J Clin Endocrinol Metab 2015 (48)
>30 pmol/L = no central diabetes insipidus Negative predictive value 95%, sensitivity 94%
Hypernatremia in hospitalized patients Plasma sodium >155 mmol/L ≤4.4 pmol/L = central diabetes insipidus Sensitivity 100%, specificity 99% Nigro N, et al. Crit Care 2018 (49)
Hyponatremia in hospitalized patients Plasma sodium <125 mmol/L >84 pmol/L = hypovolemic hyponatremia Sensitivity 23%, specificity 90% Nigro N, et al. Clin Endocrinol 2017 (50)
<3.9 pmol/L = primary polydipsia Sensitivity 58%, specificity 91%